Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease (Q43582240)

24 November 2017

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease (English)

1 reference

24 November 2017

anti-retroviral agent

0 references

0 references

3

C Katlama

1 reference

24 November 2017

T S Li

1

1 reference

24 November 2017

R Tubiana

2

1 reference

24 November 2017

V Calvez

4

1 reference

24 November 2017

H Ait Mohand

5

1 reference

24 November 2017

B Autran

6

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

24 November 2017

5

1 reference

inferred from page(s)

published in

The Lancet

1 reference

24 November 2017

351

1 reference

24 November 2017

9117

1 reference

24 November 2017

1682-1686

1 reference

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

Decline in deaths from AIDS due to new antiretrovirals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

Augmentation of Cellular Immune Function during the Early Phase of Zidovudine Treatment of AIDS Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

Reconstitution of long-term T helper cell function after zidovudine therapy in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

Immune reconstitution in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2910291-4

7 January 2021

10.1016/S0140-6736(97)10291-4

Identifiers

DOI

1 reference

24 November 2017

1 reference